About This Video
For more info visit www.newsinfusion.com
GARDASIL Now Approved for Use in both Males and Females in the U.S.
GARDASIL is not recommended for use in pregnant women.
The most common adverse reaction was headache. Common adverse reactions that were observed among recipients of GARDASIL at a frequency of at least 1.0 percent and greater than placebo were: fever, nausea, dizziness; and injection-site pain, swelling, erythema, pruritus and bruising.
The Prescribing Information and Patient Product Information for GARDASIL is attached and available at: http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf
http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_ppi.pdf
This website uses Adobe® Flash™ Player 9
Download Flash Now
If you are using Internet Explorer, you will need to restart your browser
after installing Flash.
Adobe and Flash are registered trademarks of Adobe Systems incorporated.
All rights reserved.
